TGA ponders ban reversal appeal

Following a fierce legal battle, the Administrative Appeals Tribunal (AAT) decided the controversial drugs should remain on the Australian Register of Therapeutic Goods (ARTG), subject to conditions which have been described as “deprofessionalising” to GPs.

These conditions stated that manufacturer Aspen Healthcare could only supply the drugs, already banned in the UK and US because of their potential to trigger arrhythmias, to pharmacists who had agreed that patients must possess a